These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Accuracy and reproducibility of a cone beam CT-based virtual parenchymal perfusion algorithm in the prediction of SPECT/CT anatomical and volumetric results during the planification of radioembolization for HCC. Derbel H; Krichen M; Chalaye J; Saccenti L; Van der Sterren W; Muris AH; Lerman L; Galletto A; Zaarour Y; Luciani A; Kobeiter H; Tacher V Eur Radiol; 2023 May; 33(5):3510-3520. PubMed ID: 36651956 [TBL] [Abstract][Full Text] [Related]
6. Quantitative differences in volumetric calculations for radiation dosimetry in segmental Y90 treatment planning using hybrid angiography-CT compared with anatomic segmentation. Kwak DH; Lionberg A; Patel M; Nijhawan K; Martens S; Yu Q; Cao D; Youssef S; Ahmed O Br J Radiol; 2024 Feb; 97(1154):353-362. PubMed ID: 38308040 [TBL] [Abstract][Full Text] [Related]
7. Intraprocedural C-arm dual-phase cone-beam enhancement patterns correlate with tumor absorbed dose after radioembolization. Bastiaannet R; Lin M; Frey EC; de Jong HWAM Med Phys; 2024 Apr; 51(4):3045-3052. PubMed ID: 38064591 [TBL] [Abstract][Full Text] [Related]
8. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma. Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647 [TBL] [Abstract][Full Text] [Related]
9. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study. Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133 [TBL] [Abstract][Full Text] [Related]
10. Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization. Louie JD; Kothary N; Kuo WT; Hwang GL; Hofmann LV; Goris ML; Iagaru AH; Sze DY J Vasc Interv Radiol; 2009 May; 20(5):606-13. PubMed ID: 19345589 [TBL] [Abstract][Full Text] [Related]
11. (90)Y Radioembolization: Multimodality Imaging Pattern Approach with Angiographic Correlation for Optimized Target Therapy Delivery. Camacho JC; Moncayo V; Kokabi N; Reavey HE; Galt JR; Yamada K; Kies DD; Williams RS; Kim HS; Schuster DM Radiographics; 2015; 35(5):1602-18. PubMed ID: 26230755 [TBL] [Abstract][Full Text] [Related]
12. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma. Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366 [TBL] [Abstract][Full Text] [Related]
13. Use of dose-volume histograms for metabolic response prediction in hepatocellular carcinoma patients undergoing transarterial radioembolization with Y-90 resin microspheres. Coskun N; Kartal MO; Kartal AS; Cayhan V; Ozdemir M; Canyigit M; Ozdemir E Ann Nucl Med; 2024 Jul; 38(7):525-533. PubMed ID: 38647875 [TBL] [Abstract][Full Text] [Related]
15. Metabolic activity assessment by Kim DY; Lee HW; Kang W; Kim GM; Won JY; Yun M J Gastroenterol Hepatol; 2021 Jun; 36(6):1679-1684. PubMed ID: 33226706 [TBL] [Abstract][Full Text] [Related]
16. Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion. Reiner CS; Morsbach F; Sah BR; Puippe G; Schaefer N; Pfammatter T; Alkadhi H J Vasc Interv Radiol; 2014 May; 25(5):747-59. PubMed ID: 24630751 [TBL] [Abstract][Full Text] [Related]
17. Analysis of dynamic hepatobiliary contrast-enhanced MRI signal intensity after Yttrium-90 radioembolization with glass microspheres for the treatment of hepatocellular carcinoma. Syed M; Shah J; Montazeri SA; Grajo JR; Geller B; Toskich B Abdom Radiol (NY); 2021 May; 46(5):2182-2187. PubMed ID: 33216180 [TBL] [Abstract][Full Text] [Related]
18. Same-Day Yttrium-90 Radioembolization: Feasibility with Resin Microspheres. Li MD; Chu KF; DePietro A; Wu V; Wehrenberg-Klee E; Zurkiya O; Liu RW; Ganguli S J Vasc Interv Radiol; 2019 Mar; 30(3):314-319. PubMed ID: 30819470 [TBL] [Abstract][Full Text] [Related]
19. Utility of Early Posttreatment PET/CT Evaluation Using FDG or Reizine E; Chalaye J; Mule S; Regnault H; Perrin C; Calderaro J; Laurent A; Amaddeo G; Kobeiter H; Tacher V; Itti E; Luciani A AJR Am J Roentgenol; 2022 Feb; 218(2):359-369. PubMed ID: 34494448 [No Abstract] [Full Text] [Related]
20. Direct comparison and reproducibility of two segmentation methods for multicompartment dosimetry: round robin study on radioembolization treatment planning in hepatocellular carcinoma. Lam M; Garin E; Palard-Novello X; Mahvash A; Kappadath C; Haste P; Tann M; Herrmann K; Barbato F; Geller B; Schaefer N; Denys A; Dreher M; Fowers KD; Gates V; Salem R Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):245-257. PubMed ID: 37698645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]